BNGO Bionano Genomics, Inc.
Healthcare$1.22-1.61%ClosedMarket Cap: $4.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.18
P/S
0.14
EV/EBITDA
-0.32
DCF Value
$-119.55
FCF Yield
-474.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
47.0%
Operating Margin
-114.0%
Net Margin
-109.9%
ROE
-71.4%
ROA
-48.8%
ROIC
-60.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $6.7M | 48.6% | $-7.9M | $-8.3M | $— | — |
| Q4 null | $8.0M | 42.7% | $-8.5M | $-7.9M | $— | — |
| FY null | $28.5M | 22.0% | $-33.3M | $-26.4M | $— | — |
| Q3 null | $7.4M | 45.7% | $-8.5M | $-8.5M | $— | — |
| Q2 null | $6.7M | 51.6% | $-7.8M | $-6.9M | $— | — |
| Q1 null | $6.5M | 45.5% | $-8.5M | $-3.1M | $— | — |
| Q4 null | $8.2M | 41.9% | $-11.9M | $-20.1M | $— | — |
| FY null | $30.8M | 1.2% | $-104.0M | $-112.0M | $— | — |
| Q3 null | $6.1M | -139.1% | $-43.9M | $-44.2M | $— | — |
| Q2 null | $7.8M | 33.3% | $-17.0M | $-16.2M | $— | — |
| Q1 null | $8.8M | 32.2% | $-31.1M | $-31.4M | $— | — |
| Q4 2023 | $10.7M | 22.7% | $-20.0M | $-43.9M | $-3,970.20 | — |